ACR Highlights… ACR Convergence 2025 Highlights- Paediatric rheumatology 24 Nov 2025 Efficacy of Tumor Necrosis Factor Inhibitors in Children Diagnosed With Non-Systemic Juvenile Idiopathic Arthritis <2 Years Old Using The Childhood Arthritis and Rheumatology Research Alliance Registry Abstract format and assignment…
ACR Highlights… ACR Convergence 2024 Highlights – Paediatrics 19 Dec 202419 Dec 2024 Epstein-Barr Virus Infection Triggers Hyperinflammation and Cytokine Storm in Healthy Children Abstract format and assignment number: Oral presentation 0829 Presenting author: P. Lee (USA) Date: Saturday, 16th November 2024 This…
EULAR 2024 Highlights… EULAR 2024 Highlights – Paediatrics 21 Jul 2024 Author: Raquel Campanilho-Marques V. Ø. Dåstøl et al. (OP0316) investigated the association between maternal fish consumption, dietary mercury exposure during pregnancy, and risk of Juvenile Idiopathic Arthritis (JIA) in offspring.…
ACR Highlights… ACR Convergence Highlights 2023 – Paediatric Rheumatology 9 Dec 20239 Dec 2023 Author: Jessica Perfetto Matt et al. (0363) assessed clinical, inflammatory, and pulmonary outcomes of post-allogenic hematopoietic stem cell transplant (HSCT) in an international cohort of children with refractory systemic JIA…
ACR Congress Do Not Miss… ACR Convergence 2023: Do Not Miss – Paediatric Rheumatology 6 Nov 20238 Nov 2023 Sónia Melo GomesSónia is a Clinical Research Fellow who recently finished her PhD in genetics of Autoinflammation at the UCL GOSH Institute of Child Health in London, UK. She is…
Paediatric Rheumatology… Paediatric Rheumatology 29 May 202330 May 2023 Selcan Demir Selcan is a pediatric rheumatologist at Eskisehir Osmangazi University. Her major interests include juvenile SLE and APS. Selcan is a member of EMERGE and leading the clinical affair committee of the PRES SLE…
Paediatric Rheumatology [ACR22] Paediatric Rheumatology 29 Nov 20226 Dec 2022 Author: Thomas Renson Ramanan et al (2210) presented phase 3 efficacy and safety data of baricitinib in 220 (non-systemic) juvenile idiopathic arthritis (JIA) patients. 63.5% of the patients achieved a…